- Home
- GBR vs BGLC Comparison
GBR vs BGLC Comparison
Compare GBR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBR
- BGLC
- Stock Information
- Founded
- GBR 1978
- BGLC 2017
- Country
- GBR United States
- BGLC Malaysia
- Employees
- GBR N/A
- BGLC N/A
- Industry
- GBR Oil & Gas Production
- BGLC Medical Specialities
- Sector
- GBR Energy
- BGLC Health Care
- Exchange
- GBR Nasdaq
- BGLC Nasdaq
- Market Cap
- GBR 6.1M
- BGLC 5.8M
- IPO Year
- GBR N/A
- BGLC N/A
- Fundamental
- Price
- GBR $1.18
- BGLC $0.38
- Analyst Decision
- GBR
- BGLC
- Analyst Count
- GBR 0
- BGLC 0
- Target Price
- GBR N/A
- BGLC N/A
- AVG Volume (30 Days)
- GBR 57.9K
- BGLC 10.9M
- Earning Date
- GBR 11-13-2024
- BGLC 02-20-2025
- Dividend Yield
- GBR N/A
- BGLC N/A
- EPS Growth
- GBR N/A
- BGLC N/A
- EPS
- GBR N/A
- BGLC N/A
- Revenue
- GBR $147,000.00
- BGLC $9,259,858.00
- Revenue This Year
- GBR N/A
- BGLC N/A
- Revenue Next Year
- GBR N/A
- BGLC N/A
- P/E Ratio
- GBR N/A
- BGLC N/A
- Revenue Growth
- GBR N/A
- BGLC N/A
- 52 Week Low
- GBR $0.96
- BGLC $0.21
- 52 Week High
- GBR $1.82
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- GBR 50.47
- BGLC 59.27
- Support Level
- GBR $1.16
- BGLC $0.33
- Resistance Level
- GBR $1.24
- BGLC $0.41
- Average True Range (ATR)
- GBR 0.07
- BGLC 0.11
- MACD
- GBR 0.00
- BGLC 0.01
- Stochastic Oscillator
- GBR 25.45
- BGLC 23.68
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.